The Parkland Foundation and Parkland Center for Clinical Innovation appointed Steve Miff, PhD, as PCCI’s new president and CEO effective Jan. 23.
Miff comes from Vizient and Sg2, previously serving as the senior vice president of Vizient and as general manager and senior vice president of Sg2. He also has 15 years of experience in PCCI’s core domain.
Ted Shaw, chair of the PCCI board and CEO of the Texas Hospital Association, says Miff will lead PCCI as it continues to innovate and grow its transformative work in the healthcare sector.
Miff’s ideas include working with PCCI’s eclectic team of physicians, clinicians, data scientists, and healthcare professionals to utilize scientific research and analytics to radically improve healthcare.
“I believe that revolutionary change in our industry will come from the application of advanced analytics and intelligence at the point of care,” Miff said in an interview. “PCCI is aiming to do just that.”
He also hopes to leverage the local ecosystem in Dallas, specifically with Parkland Health and PCCI’s sister company, Pieces Technologies Inc., to create rapid cycles of innovation and build on analytics.
“The patient population that Parkland and its partners serve is diverse with broad needs,” Miff said. “If we can make significant impact in our community, in the Dallas community, we can translate that and make it anywhere in the country.”
Miff will succeed PCCI founder Ruben Amarasingham, MD, who has led PCCI since its inception in 2012. Amarasingham also serves as CEO of Pieces Technologies, and now will focus on the Pieces Tech operation. The enterprises will continue collaborating and working closely together.
“As I turn my efforts to the growth of Pieces Tech, I am delighted that Steve Miff will be assuming the helm at PCCI,” Amarasingham said in a statement. “He will have a profound impact on PCCI’s trajectory and innovation, as we partner with health systems and research organizations locally and nationally, beginning at Parkland.”
Miff says other strategic plans for PCCI include innovation and creating new products, company growth, and collaborating with leading providers and organizations across the country and internationally.
“This is still a work in progress, but I envision PCCI being able to guide the delivery of personalized and precision medicine at the point of care for each individual in every community,” he said.
PCCI develops and consults on data and clinical science programs to impact healthcare delivery while lowering costs. It is an independent, not-for-profit organization created by Parkland Healthcare System. PCCI is a recipient of more than $45 million in grants directed toward building collaborative community health initiatives, developing new technologies at Parkland, and managing chronic diseases.